ABEO
NASDAQ · Biotechnology
Abeona Therapeutics Inc
$5.40
-0.03 (-0.55%)
Open$5.45
Previous Close$5.43
Day High$5.48
Day Low$5.34
52W High$7.65
52W Low$4.00
Volume—
Avg Volume1.72M
Market Cap309.37M
P/E Ratio—
EPS$-1.12
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+160.9% upside
Current
$5.40
$5.40
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.01M | 3.13M | 39.71M |
| Net Income | 61.32M | 34.40M | -4,431,314 |
| Profit Margin | 1,223.1% | 1,161.9% | -11.2% |
| EBITDA | 56.40M | 33.40M | -4,969,444 |
| Free Cash Flow | — | — | -4,447,710 |
| Rev Growth | +60.4% | +60.4% | +12.5% |
| Debt/Equity | 0.13 | 0.13 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |